Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 35, Issue 5, Pages 581–588
http://dx.doi.org/10.1155/2013/582569
Research Article

Mutation of NPM1 and FLT3 Genes in Acute Myeloid Leukemia and Their Association with Clinical and Immunophenotypic Features

1National Institute of Pathology, Indian Council of Medical Research, Safdarjung Hospital Campus, New Delhi 110029, India
2Department of Hematology, Safdarjung Hospital, New Delhi 110029, India

Received 10 April 2013; Revised 1 October 2013; Accepted 2 October 2013

Academic Editor: Benoit Dugue

Copyright © 2013 Pradeep Singh Chauhan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Gary Gilliland and J. D. Griffin, “The roles of FLT3 in hematopoiesis and leukemia,” Blood, vol. 100, no. 5, pp. 1532–1542, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. J. W. Vardiman, J. Thiele, D. A. Arber et al., “The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes,” Blood, vol. 114, no. 5, pp. 937–951, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Nakao, S. Yokota, T. Iwai et al., “Internal tandem duplication of the flt3 gene found in acute myeloid leukemia,” Leukemia, vol. 10, no. 12, pp. 1911–1918, 1996. View at Google Scholar · View at Scopus
  4. F. Hayakawa, M. Towatari, H. Kiyoi et al., “Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines,” Oncogene, vol. 19, no. 5, pp. 624–631, 2000. View at Google Scholar · View at Scopus
  5. F. M. Abu-Duhier, A. C. Goodeve, G. A. Wilson, R. S. Care, I. R. Peake, and J. T. Reilly, “Identification of novel FLT-3 Asp835 mutations in adult acute myeloid leukaemia,” British Journal of Haematology, vol. 113, no. 4, pp. 983–988, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Falini, C. Mecucci, E. Tiacci et al., “Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype,” The New England Journal of Medicine, vol. 352, no. 3, pp. 254–266, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Colombo, J.-C. Marine, D. Danovi, B. Falini, and P. G. Pelicci, “Nucleophosmin regulates the stability and transcriptional activity of p53,” Nature Cell Biology, vol. 4, no. 7, pp. 529–533, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Ahmad, S. Mandava, and B. R. Das, “Mutations of NPM1 gene in de novo acute myeloid leukaemia: determination of incidence, distribution pattern and identification of two novel mutations in Indian population,” Hematological Oncology, vol. 27, no. 2, pp. 90–97, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. N. R. Dunna, S. Rajappa, R. Digumarti et al., “Fms like tyrosine kinase (FLT3) and nucleophosmin 1 (NPM1) mutations in De Novo normal karyotype acute myeloid leukemia (AML),” Asian Pacific Journal of Cancer Prevention, vol. 11, no. 6, pp. 1811–1816, 2010. View at Google Scholar · View at Scopus
  10. P. S. Chauhan, B. Bhushan, A. K. Mishra et al., “Mutation of FLT3 gene in acute myeloid leukemia with normal cytogenetics and its association with clinical and immunophenotypic features,” Medical Oncology, vol. 28, no. 2, pp. 544–551, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. P. S. Chauhan, B. Bhushan, L. C. Singh et al., “Expression of genes related to multiple drug resistance and apoptosis in acute leukemia: response to induction chemotherapy,” Experimental and Molecular Pathology, vol. 92, no. 1, pp. 44–49, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. R. E. Gale, C. Green, C. Allen et al., “The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia,” Blood, vol. 111, no. 5, pp. 2776–2784, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Döhner, E. H. Estey, S. Amadori et al., “Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet,” Blood, vol. 115, no. 3, pp. 453–474, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Suzuki, H. Kiyoi, K. Ozeki et al., “Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemia,” Blood, vol. 106, no. 8, pp. 2854–2861, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Thiede, S. Koch, E. Creutzig et al., “Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML),” Blood, vol. 107, no. 10, pp. 4011–4020, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Boonthimat, W. Thongnoppakhun, and C. U. Auewarakul, “Nucleophosmin mutation in Southeast Asian acute myeloid leukemia: eight novel variants, FLT3 coexistence and prognostic impact of NPM1/FLT3 mutations,” Haematologica, vol. 93, no. 10, pp. 1565–1569, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. W.-C. Chou, J.-L. Tang, L.-I. Lin et al., “Nucleophosmin mutations in de novo acute myeloid leukemia: the age-dependent incidences and the stability during disease evolution,” Cancer Research, vol. 66, no. 6, pp. 3310–3316, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Shimada, T. Taki, C. Kubota et al., “No nucleophosmin mutations in pediatric acute myeloid leukemia with normal karyotype: a study of the Japanese Childhood AML Cooperative Study Group,” Leukemia, vol. 21, no. 6, article 1307, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Thiede, E. Creutzig, D. Reinhardt, G. Ehninger, and U. Creutzig, “Different types of NPM1 mutations in children and adults: evidence for an effect of patient age on the prevalence of the TCTG-tandem duplication in NPM1-exon 12,” Leukemia, vol. 21, no. 2, pp. 366–367, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Y. Hsu and B. Yung, “Involvement of nucleophosmin/B23 in TPA-induced megakaryocytic differentiation of K562 cells,” British Journal of Cancer, vol. 89, no. 7, pp. 1320–1326, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Döhner, R. F. Schlenk, M. Habdank et al., “Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations,” Blood, vol. 106, no. 12, pp. 3740–3746, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Braoudaki, C. Papathanassiou, K. Katsibardi, N. Tourkadoni, K. Karamolegou, and F. Tzortzatou-Stathopoulou, “The frequency of NPM1 mutations in childhood acute myeloid leukemia,” Journal of Hematology and Oncology, vol. 3, article 41, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Kiyoi, R. Ohno, R. Ueda, H. Saito, and T. Naoe, “Mechanism of constitutive activation of FLT3 with internal tandem duplication in the juxtamembrane domain,” Oncogene, vol. 21, no. 16, pp. 2555–2563, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. J. L. Rocnik, R. Okabe, J.-C. Yu et al., “Roles of tyrosine 589 and 591 in STAT5 activation and transformation mediated by FLT3-ITD,” Blood, vol. 108, no. 4, pp. 1339–1345, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Wang, D. Lin, X. Zhang, S. Chen, M. Wang, and J. Wang, “Analysis of FLT3 internal tandem duplication and D835 mutations in Chinese acute leukemia patients,” Leukemia Research, vol. 29, no. 12, pp. 1393–1398, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Colovic, N. Tosic, S. Aveic et al., “Importance of early detection and follow-up of FLT3 mutations in patients with acute myeloid leukemia,” Annals of Hematology, vol. 86, no. 10, pp. 741–747, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Meshinchi, T. A. Alonzo, D. L. Stirewalt et al., “Clinical implications of FLT3 mutations in pediatric AML,” Blood, vol. 108, no. 12, pp. 3654–3661, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. V. Rausei-Mills, K. L. Chang, K. K. Gaal, L. M. Weiss, and Q. Huang, “Aberrant expression of CD7 in myeloblasts is highly associated with de novo acute myeloid leukemias with FLT3/ITD mutation,” American Journal of Clinical Pathology, vol. 129, no. 4, pp. 624–629, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Schessl, V. P. S. Rawat, M. Cusan et al., “The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in mice,” Journal of Clinical Investigation, vol. 115, no. 8, pp. 2159–2168, 2005. View at Publisher · View at Google Scholar · View at Scopus